Trial intelligence / Profile preview

Aseptic Protocol for Catheter Insertion to Reduce UTIs

NCT03101371Phase 2

Key facts

Status
Completed
Start
Oct 2017
Primary completion
Feb 2019
Countries
1
Sponsor
University of Colorado Denver
Modality
Small Molecules
Conditions
catheter-associated urinary tract infection (CAUTI)
01

Overview

Phase 2, randomised, open-label trial of povidone-iodine in catheter-associated urinary tract infection (CAUTI) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) at 14 days. Started Oct 2017; status: completed.

02

Design

2 arms
Study design
RandomizedOpen-label
  • Standard of Care

    Standard catheter insertion

  • Aseptic Protocol

    Povidone-iodine treated catheter insertion

03

Who it enrols

Adult women (18-89) admitted for surgery lasting >1 hour requiring a urinary catheter, with normal pre-surgery urine analysis. Excludes patients on dialysis, with chronic urinary infection, hyperthyroidism, current infection, iodine allergy, or who are pregnant/breastfeeding.

04

Endpoints

Primary

  • Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI)

Secondary

  • Number of Participants Who Received the 'Fill and Pull' Versus the 'Pull and Void' Method of Catheter Discontinuation

  • Average Patient Satisfaction

  • Number of Participants With Extended Hospital Stay Due to a Urinary Tract Infection (UTI)

  • Number of Participants With Closed Drainage System Disrupted During Placement of Catheter

  • Number of Participants That Were Readmitted, Had Additional Clinic Visits or Went to the Emergency Department (ED) for Any Reason

  • Number of Patients That Used Antibiotics at the Time of Surgery and Post-surgery

Beyond the preview

Go deeper on NCT03101371.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03101371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call